Skip to content

Author

M. Yamawaki

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Periprocedural Pulmonary Hypertension and Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair.

BACKGROUND Pulmonary hypertension (PH) is common in patients undergoing mitral valve transcatheter edge-to-edge repair (M-TEER), but the prognostic significance of periprocedural PH changes remains uncertain. OBJECTIVES This study sought to evaluate the association between periprocedural PH patterns and clinical outc...

J. Miyamoto, Yohei Ohno, S. Noda et al. · 1 citation
Open access Sep 2026

Acute Valve Syndrome in Patients With Primary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.

BACKGROUND Acute or advanced valve syndrome (AVS), originally proposed in aortic stenosis to describe rapid clinical deterioration, has not been evaluated in mitral regurgitation (MR). OBJECTIVES This study sought to investigate the prognostic impact of AVS in patients with primary MR undergoing mitral transcatheter...

D. Miyahara, Izumo Masaki, S. Kuwata et al. · 1 citation
Aug 2026

Early Transcatheter Edge-to-Edge Repair is Associated with Improved Mid-term Outcomes in Degenerative Mitral Regurgitation.

Current guidelines offer limited guidance on the optimal timing of mitral transcatheter edge-to-edge repair (M-TEER) in degenerative mitral regurgitation (DMR). We evaluated whether the interval between diagnosis of DMR with heart failure (HF) and M-TEER was associated with clinical outcomes. We analyzed 1,061 patients...

T. Shimura, M. Yamamoto, I. Kawamura et al. · 0 citations
Open access Aug 2026

Mitral Transcatheter Edge-to-Edge Repair in Ventricular Functional Mitral Regurgitation and Very Severe Left Ventricular Dysfunction

In patients with ventricular functional MR and LVEF <20%, M-TEER was feasible and associated with meaningful symptomatic improvement without excess risk of death or HF hospitalization, although CV mortality remained higher, likely reflecting advanced myocardial disease.

Kazunori Omote, Masanori Yamamoto, Atsushi Sugiura et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.